Omada Health, Inc. OMDA
Set alert
18.59 USD +0.74 +4.17%
As of Nov 3, 10:42 AM ET
17.92 Day range 18.62
10.28 52-week range 25.61
- YTD
- +17.84%
- 1 year
- -27.56%
- Open
- 17.92
- Prev close
- 17.85
- Mkt cap
- 1.14B
- Vol
- 63.43K
- Avg vol
- 1.32M
- EPS
- 0.24
- P/E
- 77.46
- Div yield
- 0.00%
More statistics
- Low
- 17.92
- High
- 18.62
- Forward P/E
- 32.10
- Beta
- 0.00
- Short ratio
- 5.58
- Inst. own
- 88.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 20.75
- 200-d avg
- 17.68
- 1y target
- 28.17
3M chart
Events in this range
- Aug 6, 2026Earnings: 0.15; estimate 0.0622; surprise 141.16%
- Sep 11, 2026Rating: BTIG · Buy → Buy
- Sep 11, 2026Rating: Needham · Buy → Buy
- Sep 11, 2026Rating: Barclays · Overweight → Overweight
- Sep 14, 2026Rating: Freedom Capital Markets · Buy → Buy
- Oct 14, 2026Rating: Freedom Capital Markets · Buy → Buy
- Oct 28, 2026Rating: Barclays · Overweight → Overweight
Signals (18)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 3, 2026 | 1 hour ago |
| MACD: Sell Signal | Nov 2, 2026 | 1 day ago |
| MACD: Buy Signal | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 2 months ago |
| SMA: Bullish | Sep 4, 2026 | 2 months ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 3 months ago |
Financial health
Altman Z-Score
8.54 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 2
- Return on Assets 3
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -71.7×
FY 2022 5y median -23.0× FY 2025
P/S 3.5×
FY 2022 5y median 9.0× FY 2025
P/B 4.0×
FY 2022 5y median 10.6× FY 2025
P/FCF 54.5×
FY 2022 5y median -21.1× FY 2025
EV/EBITDA -147×
FY 2022 5y median -26.6× FY 2025
EV/Sales 2.7×
FY 2022 5y median 8.5× FY 2025
FCF Yield 1.8%
FY 2022 5y median -3.5% FY 2025
Profitability
Gross Margin 65.7%
FY 2022 5y median 58.8% FY 2025
Operating Margin -4.6%
FY 2022 5y median -39.7% FY 2025
Net Margin -4.9%
FY 2022 5y median -41.4% FY 2025
ROE -5.6%
FY 2022 5y median -57.4% FY 2025
ROIC -5.2%
FY 2022 5y median -41.7% FY 2025
ROA -4.2%
FY 2022 5y median -32.0% FY 2025
Growth (YoY)
Revenue 53.2%
FY 2022 FY 2025
Operating Income 72.6%
FY 2022 FY 2025
EPS (diluted) 74.1%
FY 2022 FY 2025
Free Cash Flow 144.5%
FY 2022 FY 2025
Financial Health
Current Ratio 3.6×
FY 2022 5y median 3.4× FY 2025
Quick Ratio 3.5×
FY 2022 5y median 3.4× FY 2025
Debt / Equity 0.0×
FY 2022 5y median 0.3× FY 2025
Net Debt / EBITDA 46.7×
FY 2022 5y median 1.8× FY 2025
Interest Coverage -4.7×
FY 2022 5y median -11.9× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31